Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
1.055
-0.025 (-2.31%)
At close: Jul 18, 2025, 4:00 PM
1.050
-0.005 (-0.47%)
After-hours: Jul 18, 2025, 7:39 PM EDT
Company Description
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States.
The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain.
It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis.
Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Tenon Medical, Inc.
| Country | United States |
| Founded | 2012 |
| IPO Date | Apr 27, 2022 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 27 |
| CEO | Steven Foster |
Contact Details
Address: 104 Cooper Court Los Gatos, California 95032 United States | |
| Phone | 408-649-5760 |
| Website | tenonmed.com |
Stock Details
| Ticker Symbol | TNON |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 0001560293 |
| CUSIP Number | 88066N303 |
| ISIN Number | US88066N3035 |
| Employer ID | 45-5574718 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Steven M. Foster | Chief Executive Officer, President and Director |
| Richard Ginn | Founder, Chief Technology Officer and Director |
| Kevin Williamson | Chief Financial Officer |
| Richard M. Ferrari | Founder and Executive Chairman |
| Steve Moscaret | Senior Vice President of Sales and Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 17, 2025 | DEF 14A | Other definitive proxy statements |
| Jun 5, 2025 | PRE 14A | Other preliminary proxy statements |
| May 13, 2025 | 10-Q | Quarterly Report |
| Apr 16, 2025 | 424B3 | Prospectus |
| Apr 15, 2025 | EFFECT | Notice of Effectiveness |
| Apr 11, 2025 | UPLOAD | Filing |
| Apr 8, 2025 | D | Notice of Exempt Offering of Securities |
| Apr 8, 2025 | D | Notice of Exempt Offering of Securities |
| Apr 8, 2025 | D | Notice of Exempt Offering of Securities |
| Apr 4, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |